Teva misses on profit, beats analysts on revenue
The Israeli company reported non-GAAP earning per share of just $0.40, while market expectations were $0.56....…
16,925€
-1,17%
Echtzeit-Aktienkurs Teva Pharmaceutical Industries Limited
Bid:
Ask:
Nachrichten zur Teva Pharmaceutical Industries Limited Aktie
UPDATE 1-Teva Pharm Q1 net profit slides, maintains 2023 forecast
... (Reuters) - Israel-based Teva
Pharmaceutical Industries reported a drop......…
ROUNDUP: Teva Pharma Reaffirms FY23 Outlook
PETAH TIKVA (dpa-AFX) - While reporting financial results for the first quarter on Wednesday, Teva Pharmaceutical Industries Ltd (TEVA) reaffirmed…
Teva Pharm Q1 net profit slides, revenue flat
...JERUSALEM, May 10 (Reuters) - Israel-based Teva
Pharmaceutical......…
Teva Pharmaceutical Industries Limited Q1 Earnings Summary
PETAH TIKVA (dpa-AFX) - Below are the earnings highlights for Teva Pharmaceutical Industries Limited (TEVA):Earnings: -$205 million in Q1 vs.…
Form 8-K TEVA PHARMACEUTICAL INDU For: May 10
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Teva Pharmaceutical Q1 results in focus with eye on revenue numbers
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
FDA approves innovative Teva schizophrenia drug
UZEDY was developed together with MedinCells copolymer technology....…
Teva, MedinCell win FDA nod for long-acting schizophrenia therapy
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Teva Recalls FENTANYL Buccal Tablets CII
PETAH TIKVA (dpa-AFX) - Teva Pharmaceuticals USA is recalling specific lots of various strengths of FENTANYL Buccal Tablets CII to…
Teva Recalls FENTANYL Buccal Tablets CII
Teva Pharmaceuticals USA is recalling specific lots of various strengths of FENTANYL Buccal Tablets CII to the consumer level citing…
Teva paid top executives $330m while share price tanked
Over the past 10 years, Teva has paid its top five executives huge amounts while its share price fell 72%....…
Kare Schultz earned $107m during Teva tenure
Schultz who stepped down at the end of 2022 after five years at the helm will receive a further $16…
Teva: Das macht die Aktie für gewisse Anleger interessant
Die Teva-Aktie (WKN: 883035) ist in den letzten Tagen um -13% auf aktuell 7,50 € eingebrochen. Ein aktueller Grund hierfür…
Teva Shares Drop 11% After Alvotech Gets FDA Complete Response Letter
Teva Shares Drop 11% After Alvotech Gets FDA Complete Response Letter...…
Teva down 2%after receiving FDA response letter for AVT02 biologics
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Teva in pact with Neurocrine to delay Ingrezza generics
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Corporate News: ART MEDICAL
ART MEDICAL Announces Partnership With Teva Israel to Bring Its Lifesaving Technology to Critical Care Units...…
ART MEDICAL Ltd: ART MEDICAL Announces Partnership With Teva Israel to Bring Its Lifesaving Technology to Critical Care Units
ART MEDICAL Ltd. is pleased to announce its collaboration with Teva Israel. Under the terms of the agreement, Teva Israel…
Teva ends enrollment in late-stage Austedo cerebral palsy trial
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 8-K TEVA PHARMACEUTICAL INDU For: Mar 09
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Teva Pharmaceutical launches additional dosage strengths of generic Revlimid
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Insiderhandel: Exec. VP, European Commercial verkauft Aktien von Teva Pharma Industries im Wert von 178.776$
Daniell, Richard - Vorstand - Tag der Transaktion: 2023-03-06...…
Insiderhandel: Exec. VP, European Commercial verkauft Aktien von Teva Pharma Industries im Wert von 509.173$
Daniell, Richard - Vorstand - Tag der Transaktion: 2023-03-07...…
Better Generics Pharmaceutical Stock: Teva or Viatris?
Both have plans to return to growth....…
Form 8-K TEVA PHARMACEUTICAL INDU For: Mar 01
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Insiderhandel: Executive VP Global Operations verkauft Aktien von Teva Pharma Industries im Wert von 333.030$
Drape, Eric - Vorstand - Tag der Transaktion: 2023-02-28...…
Insiderhandel: Exec. VP Chief Legal Officer verkauft Aktien von Teva Pharma Industries im Wert von 626.642$
Stark, David Matthew - Vorstand - Tag der Transaktion: 2023-02-28...…
Insiderhandel: EVP, North America Commercial verkauft Aktien von Teva Pharma Industries im Wert von 589.785$
Dethlefs, Sven - Vorstand - Tag der Transaktion: 2023-02-28...…
Insiderhandel: Exec. VP, European Commercial verkauft Aktien von Teva Pharma Industries im Wert von 437.502$
Daniell, Richard - Vorstand - Tag der Transaktion: 2023-02-28...…
Teva announces debt recycling measures
The Israeli pharmaceutical company is to issue $2.06 billion of sustainability-linked senior notes and has begun tender offers to purchase…
Teva to raise $2.06B in sustainability-linked senior notes offering, launches $2.25B in debt tender offers for notes
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Teva Announces $2.06 Bln Senior Notes Offering, $2.25 Bln Debt Tender Offers For Notes
PETAH TIKVA (dpa-AFX) - Teva Pharmaceutical Industries Ltd. (TEVA) announced Monday its intention to issue $2.06 billion equivalent of sustainability-linked…
Teva: Was Deutschland-Chef Andreas Burkhardt am snowboarden so liebt
Snowboarder sitzen nur am Hang rum und schieben den Schnee nach unten? Mit diesem Vorurteil kann Andreas Burkhardt, Deutschland-Chef von…
Teva Gets FDA Approval for Movement Disorders Treatment
Teva Gets FDA Approval for Movement Disorders Treatment...…
Protein Inhibitors Global Market Report 2023
NEW YORK, Feb. 16, 2023 /PRNewswire/ -- Major players in the protein inhibitors market are Bayer AG, Astra Zeneca, Roche,…
Teva Unveils Spring 2023 Collection
GOLETA, Calif., Feb. 16, 2023 /PRNewswire/ -- Teva®, a division of Deckers Brands (NYSE: DECK), announces the arrival of its…
Global Digital Respiratory Devices Market Report to 2030 - Featuring Cohero Health, Cognita Labs, Adherium, Amiko Digital Health and Teva Pharmaceuticals Industries Among Others
DUBLIN, Feb. 13, 2023 /PRNewswire/ -- The "Digital Respiratory Devices Market Size, Share & Trends Analysis Report by Product (Smart…
Rituximab Biosimilars Global Market Report 2023
NEW YORK, Feb. 13, 2023 /PRNewswire/ -- Major players in the rituximab biosimilars market are Pfizer Inc., Mylan Inc., Amgen…
Axsome slips as Teva seeks generic for depression therapy
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 10-K TEVA PHARMACEUTICAL INDU For: Dec 31
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
TEVA Pharmaceutical: Kursziel gesteigert
London (www.aktiencheck.de) - Rating-Update:
Balaji Prasad, Analyst von Barclays, bestätigt das Rating "overweight" für die Aktie von TEVA Pharmaceutical Industries Ltd.…
Teva Pharma Agrees To Settle Price-Fixing Claims With Florida
PETAH TIKVA (dpa-AFX) - Teva Pharmaceutical Industries Ltd. (TEVA) announced Thursday that its U.S. affiliate Teva Pharma signed an agreement…
Teva to pay ~$6.7M to Florida to settle price fixing claims
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Teva Pharmaceutical Industries (TEVA) Q4 2022 Earnings Call Transcript
TEVA earnings call for the period ending December 31, 2022....…
UPDATE 2-Teva Pharmaceutical meets forecasts, but 2023 outlook disappoints
...
JERUSALEM, Feb 8 (Reuters) - Teva Pharmaceutical
Industries, the worlds......…
Teva reports heavy losses, sees minimal 2023 growth
New Teva CEO Richard Francis: We continued to optimize our supply chain and manufacturing capabilities and reduced our net debt....…
Teva issues in line guidance as North American revenue remains flat
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
ROUNDUP: Teva Issues FY23 Adj. Earnings, Revenue Outlook
PETAH TIKVA (dpa-AFX) - Teva Pharmaceutical Industries Limited (TEVA), while announcing sharply wider net loss and weak revenues in its…
Teva Pharmaceutical Industries Limited Q4 Earnings Summary
PETAH TIKVA (dpa-AFX) - Below are the earnings highlights for Teva Pharmaceutical Industries Limited (TEVA):Earnings: -$1.22 billion in Q4 vs.…